Synopsis: A tech company posts record earnings and 24 straight quarters of growth – yet its stock falls 10 Percent in a week. The reason is hiding in plain sight.
Imagine a company that just reported its highest-ever quarterly revenue, grew its profit by 34 Percent, and hasn’t had a single bad quarter in six years. Now imagine its stock falling 10 Percent in a week. That’s exactly what happened here – and it tells you everything about how the stock market really works. Sometimes, good is simply not good enough.
With a market cap of Rs. 75,617 crore,the shares of Persistent Systems Ltd. made a high of Rs. 4,909 in Wednesday trading session and closed at a price of Rs. 4,805. It is currently trading at a P/E of 39. Why the Market Punished a 34 Percent Profit Jump?
When “Good Enough” Isn’t Good Enough
At a P/E of 39x – nearly double the industry average of 22.5x – investors are already paying a massive premium for this stock. That means they expect the company to keep growing fast – quarter after quarter, without fail. In Q4 FY26, revenue hit a record Rs.4,056 crore, up 25 Percent from Rs.3,242 crore in Q4 FY25. Full-year revenue came in at Rs.14,748 crore, growing 23.5 Percent year-on-year. These are solid numbers by any measure. But at nearly twice the industry valuation, the market was hoping for something even better. When expectations are sky-high, even a decent result can feel like a disappointment – and the stock pays the price.
The Margin Number That Made Investors Nervous
Profit after tax grew 33.6 Percent to Rs.529 crore in Q4 FY26 – a number most companies would be proud of. Full-year PAT came in at Rs.1,865 crore, up from Rs.1,400 crore in FY25. But investors were looking closely at EBIT margin, which measures how efficiently the business is actually running before interest and taxes. The Q4FY26 EBIT margin came in at 16.3 Percent, weighed down by a one-time cost from new labour code compliance.
Smart money looks past headline profits and asks: how much of this is coming from core operations? When margins are pressured by one-off charges and currency gains are helping the bottom line, investors start questioning the quality of earnings – not just the size. The company also declared a final dividend of Rs 18 per share, taking the total FY26 dividend to Rs 40 per share versus Rs 35 in FY25.
A Dip in New Deal Wins Raised Questions
Every quarter, analysts track how much new business the company is signing up – because today’s deals become tomorrow’s revenue. In Q4 FY26, new deal wins came in at roughly $408.9 million , which looks healthy on its own. But the trailing twelve-month total contract value including renewals slipped from roughly $674.5 million in Q3 to around $600.8 million in Q4 – a drop of about 12 Percent. For a company trading at 39x earnings, investors aren’t just paying for what the business did last quarter. They’re paying for what it’s going to do in the next three to five years. Any sign that the deal pipeline might be slowing down is enough to trigger a sell-off.
Charts Turned Red and Selling Snowballed
Once the results disappointed traders, the charts did the rest of the damage. The stock broke below its 50-day, 100-day, and 200-day moving averages one after another. For large funds and algorithmic traders, crossing below these levels is an automatic trigger to sell. Once those big players start selling, the stock drops further, which scares retail investors into selling too – and the cycle feeds on itself. A 10 Percent fall in a week is not unusual when technicals and fundamentals both turn negative at the same time.
Segmental Performance: Q4 FY26 Overview
In the fourth quarter of FY26, Persistent Systems demonstrated robust, broad-based performance across its primary industry segments. The Software, Hi-Tech & Emerging Industries vertical remained the largest contributor, generating $170.8 million in revenue with 14.1% year-on-year growth. Banking, Financial Services & Insurance (BFSI) followed with $150.4 million, achieving the highest year-on-year growth rate of 15.3%. Meanwhile, the Healthcare & Life Sciences segment contributed $114.8 million, marking a 22.0% increase compared to the previous year. This growth was further supported by a record total contract value (TCV) of $600.8 million for the quarter.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Why Is the Market Selling This IT Stock Despite a 34% Profit Surge? appeared first on Trade Brains.